Torrent to Buy Unichem Labs’ India Biz

Nov 03, 2017

Torrent Pharmaceuticals announced that it will buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.

The $558 million transaction will strengthen Torrent’s position in cardiology, diabetes, gastro-intestinals and central nervous systems therapies, as well as add Torrent to the list of top pharma firms in the Indian Pharma market.

Unichem will continue to focus on international business comprising of manufacturing, selling and marketing of fixed dosage formulation and API. It will also continue to build a sustainable revenue stream by investing in R&D.

Read the press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments